Potential breast cancer prevention drug found to cause significant bone loss

A drug that has been shown to prevent breast cancer in postmenopausal women at high risk of developing the disease, and is poised for widespread use, appears to significantly worsen age-related bone loss, according to an Article published Online First in The Lancet Oncology.

Read the whole article on Physorg

More from Physorg